help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goalstone, M.
Right arrow Articles by Draznin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goalstone, M.
Right arrow Articles by Draznin, B.
Endocrinology Vol. 138, No. 12 5119-5124
Copyright © 1997 by The Endocrine Society


ARTICLES

Insulin Stimulates the Phosphorylation and Activity of Farnesyltransferase via the Ras-Mitogen-Activated Protein Kinase Pathway1

Marc Goalstone, Kirstin Carel, J. Wayne Leitner and Boris Draznin

Medical Research Service and the Department of Medicine, Veterans Affairs Medical Center and the University of Colorado Health Sciences Center, Denver, Colorado 80220

Address all correspondence and requests for reprints to: Dr. Boris Draznin, Veterans Affairs Medical Center, Chief, Section of Endocrinology (111H), 1055 Clermont Street, Denver, Colorado 80220. E-mail: bdraznin{at}sembilan.uchsc.edu

Farnesylation of p21Ras by farnesyltransferase (FTase) is obligatory for anchoring p21Ras to the plasma membrane, where it can be activated by growth factors. Insulin significantly stimulates the phosphorylation of the {alpha}-subunit of FTase (4-fold) and the enzymatic activity of FTase in 3T3-L1 fibroblasts and adipocytes. FTase activity was assessed by the amount of [3H] mevalonate (a precursor of farnesyl) incorporated into p21Ras in vivo and by quantitating the amount of farnesylated p21Ras before and after insulin administration. Insulin-stimulated phosphorylation of the {alpha}-subunit of FTase in 3T3-L1 fibroblasts and adipocytes was blocked by the mitogen-activated protein/extracellular-signal regulated kinase-kinase inhibitor, PD98059, but not by wortmannin or bisindolylmaleimide. Additionally, PD98059 blocked insulin-stimulated [3H]mevalonic incorporation and farnesylation of unprocessed p21Ras in both cell lines. Furthermore, expression of the dominant negative mutant of p21Ras precluded insulin-stimulated phosphorylation of the FTase {alpha}-subunit and activation of its enzymatic activity. In contrast, 3T3-L1 fibroblasts, expressing the constitutively active Raf-1, exhibited enhanced phosphorylation of the FTase {alpha}-subunit. It seems that insulin’s effect on the phosphorylation and activation of FTase in both fibroblasts and adipocytes is mediated via the Ras pathway, resulting in a positive feedback augmentation of the cellular pool of farnesylated p21Ras.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. F. Burrows, A. A. Kelvin, C. McFarlane, R. E. Burden, M. J. McGrattan, M. De la Vega, U. Govender, D. J. Quinn, K. Dib, M. Gadina, et al.
USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity
J. Biol. Chem., April 3, 2009; 284(14): 9587 - 9595.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. C. L. Wang, M. L. Goalstone, and B. Draznin
Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology
Diabetes, November 1, 2004; 53(11): 2735 - 2740.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Smith, M. G. Rowlands, E. Barrie, P. Workman, and L. R. Kelland
Establishment and Characterization of Acquired Resistance to the Farnesyl Protein Transferase Inhibitor R115777 in a Human Colon Cancer Cell Line
Clin. Cancer Res., June 1, 2002; 8(6): 2002 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Golovchenko, M. L. Goalstone, P. Watson, M. Brownlee, and B. Draznin
Hyperinsulinemia Enhances Transcriptional Activity of Nuclear Factor-{kappa}B Induced by Angiotensin II, Hyperglycemia, and Advanced Glycosylation End Products in Vascular Smooth Muscle Cells
Circ. Res., October 27, 2000; 87(9): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Draznin, P. Miles, Y. Kruszynska, J. Olefsky, J. Friedman, I. Golovchenko, R. Stjernholm, K. Wall, M. Reitman, D. Accili, et al.
Effects of Insulin on Prenylation as a Mechanism of Potentially Detrimental Influence of Hyperinsulinemia
Endocrinology, April 1, 2000; 141(4): 1310 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Goalstone, J. W. Leitner, I. Golovchenko, M. R. Stjernholm, M. Cormont, Y. Le Marchand-Brustel, and B. Draznin
Insulin Promotes Phosphorylation and Activation of Geranylgeranyltransferase II. STUDIES WITH GERANYLGERANYLATION OF Rab-3 AND Rab-4
J. Biol. Chem., January 29, 1999; 274(5): 2880 - 2884.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. L. Goalstone, R. Natarajan, P. R. Standley, M. F. Walsh, J. W. Leitner, K. Carel, S. Scott, J. Nadler, J. R. Sowers, and B. Draznin
Insulin Potentiates Platelet-Derived Growth Factor Action in Vascular Smooth Muscle Cells
Endocrinology, October 1, 1998; 139(10): 4067 - 4072.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Goalstone, J. W. Leitner, K. Wall, L. Dolgonos, K. I. Rother, D. Accili, and B. Draznin
Effect of Insulin on Farnesyltransferase. SPECIFICITY OF INSULIN ACTION AND POTENTIATION OF NUCLEAR EFFECTS OF INSULIN-LIKE GROWTH FACTOR-1, EPIDERMAL GROWTH FACTOR, AND PLATELET-DERIVED GROWTH FACTOR
J. Biol. Chem., September 11, 1998; 273(37): 23892 - 23896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chappell, I. Golovchenko, K. Wall, R. Stjernholm, J. W. Leitner, M. Goalstone, and B. Draznin
Potentiation of Rho-A-mediated Lysophosphatidic Acid Activity by Hyperinsulinemia
J. Biol. Chem., October 6, 2000; 275(41): 31792 - 31797.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Goalstone, J. W. Leitner, P. Berhanu, P. M. Sharma, J. M. Olefsky, and B. Draznin
Insulin Signals to Prenyltransferases via the Shc Branch of Intracellular Signaling
J. Biol. Chem., April 13, 2001; 276(16): 12805 - 12812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Klemm, J. W. Leitner, P. Watson, A. Nesterova, J. E.-B. Reusch, M. L. Goalstone, and B. Draznin
Insulin-induced Adipocyte Differentiation. ACTIVATION OF CREB RESCUES ADIPOGENESIS FROM THE ARREST CAUSED BY INHIBITION OF PRENYLATION
J. Biol. Chem., July 20, 2001; 276(30): 28430 - 28435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Montagnani, I. Golovchenko, I. Kim, G. Y. Koh, M. L. Goalstone, A. N. Mundhekar, M. Johansen, D. F. Kucik, M. J. Quon, and B. Draznin
Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells
J. Biol. Chem., January 11, 2002; 277(3): 1794 - 1799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society